Irbesartan
What is Irbesartan?
Irbesartan (CAS 138402-11-6), also referenced under development codes BMS-186295 and marketed as Avapro and Aprovel, is an angiotensin II receptor antagonist API used in the manufacture of antihypertensive drug products.
Where is Irbesartan used?
- Generic drug manufacturers and contract formulators: primary API for bioequivalent formulations after patent expiry
- Oral solid dosage forms: core API in tablets and capsules for hypertension and diabetic nephropathy
- CDMOs: combination product development, particularly fixed-dose combinations with hydrochlorothiazide
- QA and analytical laboratories use it for regulatory dossier preparation and reference standard procurement.
Commercial specifications
- Quantities from laboratory scale to multi-tonne commercial lots
- USP, Ph. Eur. and BP specifications; ICH-compliant impurity profiling for GMP-grade material
- Certificate of Analysis, DMF references and country-specific regulatory support documentation
Other Names (Synonyms)
Avapro|Aprovel|Karvea|Irbesartan BMS|SR 47436|Irbesartan Zentiva|2-Butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one